Growth Metrics

GeneDx Holdings (WGS) Other Working Capital Changes (2020 - 2026)

GeneDx Holdings has reported Other Working Capital Changes over the past 7 years, most recently at $1.0 million for Q1 2026.

  • Quarterly Other Working Capital Changes rose 133.18% to $1.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$7.8 million through Mar 2026, up 28.6% year-over-year, with the annual reading at -$12.0 million for FY2025, 237.75% down from the prior year.
  • Other Working Capital Changes was $1.0 million for Q1 2026 at GeneDx Holdings, up from -$14.4 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $11.5 million in Q3 2022 and troughed at -$14.4 million in Q4 2025.
  • The 5-year median for Other Working Capital Changes is -$542000.0 (2024), against an average of -$320588.2.
  • Year-over-year, Other Working Capital Changes surged 67711.76% in 2022 and then crashed 494.73% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$163000.0 in 2022, then tumbled by 388.96% to -$797000.0 in 2023, then crashed by 494.73% to -$4.7 million in 2024, then plummeted by 202.78% to -$14.4 million in 2025, then surged by 107.2% to $1.0 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Other Working Capital Changes are $1.0 million (Q1 2026), -$14.4 million (Q4 2025), and $995000.0 (Q3 2025).